Mechanism of Resistance to Targeted Therapy in Lung Cancer Patients

A new study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) identifies a second mutation in a gene associated with non-small-cell lung cancer (NSCLC), a discovery that helps to explain why NSCLC tumors become resistant to treatment with the cancer therapy gefitinib (Iressa)... click link for more info.

Continue to Mechanism of Resistance to Targeted Therapy in Lung Cancer Patients on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz